#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17976	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2588	853.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1878	1878	T	1158	T,G,A,C	1150,4,3,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17976	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2588	853.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1612	1612	C	1138	C,G,A	1135,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30620	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4022	947.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1920	1920	A	1268	A,T	1266,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30620	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4022	947.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2554	2554	C	1092	C,T,G	1089,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30620	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4022	947.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2628	2628	A	998	A	997	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30620	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4022	947.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3180	3180	C	1048	C,T,A	1046,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30620	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4022	947.6	0	HET	.	.	.	A1043G,C,T	.	1043	1043	A	1626	1626	A	1108	A,G,C,T	549,556,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30620	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4022	947.6	0	HET	.	.	.	G2872A,T	.	2872	2872	G	3455	3455	G	1178	G,A,T	911,266,1	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	0	22	blaTEM	861	580	100.0	blaTEM.l15.c4.ctg.1	901	1.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	0	22	blaTEM	861	115	100.0	blaTEM.l15.c4.ctg.2	192	2.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	27	2610	folP	852	852	99.88	folP.l15.c4.ctg.1	2081	156.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5740	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3852	185.5	1	SNP	p	S91F	0	.	.	271	273	TCC	834	836	TCC	202;205;207	T;C;C	202;205;207	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5740	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3852	185.5	1	SNP	p	D95G	0	.	.	283	285	GAC	846	848	GAC	205;206;202	G;A;C	205;206;202	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5740	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3852	185.5	1	SNP	p	D95N	0	.	.	283	285	GAC	846	848	GAC	205;206;202	G;A;C	205;206;202	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	2160	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1929	139.7	0	.	p	.	0	A39T	NONSYN	115	117	GCC	810	812	ACC	228;225;228	A;C;C	228;225;228	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	2160	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1929	139.7	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	1008	1010	CAC	267;270;274	C;A;C	267;270;274	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	2160	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1929	139.7	0	.	p	.	0	E117K	NONSYN	349	351	GAA	1044	1046	AAA	240;239;238	A;A,G,C;A	240;237,1,1;237	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	2160	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1929	139.7	1	SNP	p	G45D	0	.	.	133	135	GGC	828	830	GGC	231;231;230	G;G;C	231;231;230	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1338	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1463	114.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5692	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3433	206.6	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1667	1669	ATC	287;282;282	A,G;T;C	285,2;282;282	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5692	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3433	206.6	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1820	1822	GCA	244;248;246	G,A;C;A	241,3;248;246	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5692	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3433	206.6	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2303	2305	ATT	295;296;295	A,C;T;T	292,2;295;295	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5692	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3433	206.6	1	SNP	p	D86N	0	.	.	256	258	GAC	773	775	GAC	250;248;249	G;A,G;C	250;247,1;249	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5692	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3433	206.6	1	SNP	p	S87I	0	.	.	259	261	AGT	776	778	AGT	253;252;251	A,C;G;T	252,1;252;251	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5692	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3433	206.6	1	SNP	p	S87R	0	.	.	259	261	AGT	776	778	AGT	253;252;251	A,C;G;T	252,1;252;251	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5692	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3433	206.6	1	SNP	p	S87W	0	.	.	259	261	AGT	776	778	AGT	253;252;251	A,C;G;T	252,1;252;251	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5692	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3433	206.6	1	SNP	p	S88P	0	.	.	262	264	TCC	779	781	TCC	252;249;250	T;C;C,G	252;249;249,1	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	5068	parE	1986	1986	99.9	parE.l15.c4.ctg.1	3135	201.4	0	.	p	.	0	L659F	NONSYN	1975	1977	CTC	2509	2511	TTC	231;230;226	T;T,G;C,T	231;229,1;225,1	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	5068	parE	1986	1986	99.9	parE.l15.c4.ctg.1	3135	201.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1762	1764	GGC	328;325;324	G;G,C;C,A	328;324,1;323,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4864	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3002	202.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1573	1575	GCA	306;305;306	G,T;C,T;A	304,1;304,1;306	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4864	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3002	202.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1576	1578	ATC	306;303;302	A,T;T;C	305,1;303;302	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4864	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3002	202.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1588	1590	GTG	294;294;292	G;T,C;G,T	294;293,1;291,1	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4864	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3002	202.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1588	1590	GTG	294;294;292	G;T,C;G,T	294;293,1;291,1	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4864	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3002	202.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2092	2094	ACC	268;267;269	A,T,G;C;C,T	265,2,1;266;268,1	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4864	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3002	202.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2146	2148	GCG	269;264;267	G,A;C;G,T	268,1;264;266,1	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4864	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3002	202.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2146	2148	GCG	269;264;267	G,A;C;G,T	268,1;264;266,1	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4864	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3002	202.1	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2269	2271	GGT	260;265;265	G;G,T;T,G	260;264,1;264,1	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4864	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3002	202.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2278	2280	GGC	268;268;271	G,T;G;C,T,A	267,1;268;269,1,1	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4864	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3002	202.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2296	2298	CCG	280;281;280	C,A;C;G	279,1;281;280	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	6848	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3654	233.4	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1935	1937	CTG	268;265;265	C;T,G;G,A	268;264,1;264,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2662	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2317	143.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	864	864	C	178	C	178	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	358	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	420	42.0	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	28;33;36	T;T;A	28;33;36	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	358	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	420	42.0	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	86;86;86	C,G;A;T	85,1;86;86	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	358	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	420	42.0	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	86;86;86	A;G;T	86;86;86	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	358	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	420	42.0	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	86;86;86	T;A,T;C	86;85,1;86	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	358	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	420	42.0	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	1;1;1	G;A;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	358	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	420	42.0	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	358	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	420	42.0	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	1;1;1	A;T;C	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	358	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	420	42.0	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	1;2;2	T;C;G	1;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	358	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	420	42.0	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	358	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	420	42.0	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	2;2;2	A;G;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	358	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	420	42.0	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	358	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	420	42.0	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	2;2;3	G;T;T	2;2;3	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3838	porB1b	1035	1035	98.28	porB1b.l15.c17.ctg.1	1686	279.1	0	.	p	.	0	R143G	NONSYN	427	429	AGA	913	915	GGA	324;324;326	G,A;G,A;A,C,G	322,2;323,1;324,1,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3838	porB1b	1035	1035	98.28	porB1b.l15.c17.ctg.1	1686	279.1	0	.	p	.	0	N185S	NONSYN	553	555	AAC	1039	1041	AGC	311;310;312	A,G;G;C,A	309,1;310;311,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3838	porB1b	1035	1035	98.28	porB1b.l15.c17.ctg.1	1686	279.1	0	.	p	.	0	Y211_N212insDGQ	INS	631	631	T	1117	1117	T	317	T,G	316,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3838	porB1b	1035	1035	98.28	porB1b.l15.c17.ctg.1	1686	279.1	0	.	p	.	0	N212_S213insL	INS	634	634	A	1130	1130	C	309	C	309	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3838	porB1b	1035	1035	98.28	porB1b.l15.c17.ctg.1	1686	279.1	0	.	p	.	0	I214V	NONSYN	640	642	ATC	1138	1140	GTG	304;304;303	G,A;T,A;G,A	302,2;303,1;302,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3838	porB1b	1035	1035	98.28	porB1b.l15.c17.ctg.1	1686	279.1	0	.	p	.	0	L218F	NONSYN	652	654	CTT	1150	1152	TTT	316;316;315	T;T;T	316;316;315	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3838	porB1b	1035	1035	98.28	porB1b.l15.c17.ctg.1	1686	279.1	0	.	p	.	0	S254R	NONSYN	760	762	AGT	1258	1260	CGT	311;314;315	C;G,C;T,G	310;311,2;312,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3838	porB1b	1035	1035	98.28	porB1b.l15.c17.ctg.1	1686	279.1	1	SNP	p	G120K	0	.	.	358	360	GGT	844	846	GGT	327;335;335	G;G;T	327;335;335	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3838	porB1b	1035	1035	98.28	porB1b.l15.c17.ctg.1	1686	279.1	1	SNP	p	A121N	0	.	.	361	363	GCC	847	849	GCC	330;334;333	G;C;C	330;334;333	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3838	porB1b	1035	1035	98.28	porB1b.l15.c17.ctg.1	1686	279.1	1	SNP	p	A121D	0	.	.	361	363	GCC	847	849	GCC	330;334;333	G;C;C	330;334;333	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	12244	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	5361	284.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2249	2251	CAT	293;291;290	C,G,T;A,G;T	289,2,1;289,1;289	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1850	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1524	151.0	1	SNP	p	V57M	0	.	.	169	171	GTG	707	709	GTG	328;327;329	G;T;G	328;327;329	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
